BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 60 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,154,575 | +2.3% | 12,666,000 | +6.3% | 0.00% | 0.0% |
| Q1 2024 | $11,884,580 | -10.1% | 11,916,000 | -7.0% | 0.00% | 0.0% |
| Q4 2023 | $13,214,640 | -17.5% | 12,816,000 | -20.2% | 0.00% | 0.0% |
| Q3 2023 | $16,014,222 | +23.8% | 16,066,000 | +25.8% | 0.00% | 0.0% |
| Q2 2023 | $12,932,672 | +1.8% | 12,766,000 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $12,708,502 | -60.0% | 12,216,000 | -58.5% | 0.00% | 0.0% |
| Q4 2022 | $31,770,300 | +115.6% | 29,432,000 | +100.7% | 0.00% | 0.0% |
| Q3 2022 | $14,738,000 | +13.3% | 14,666,000 | +13.1% | 0.00% | 0.0% |
| Q2 2022 | $13,012,000 | -10.6% | 12,966,000 | -9.7% | 0.00% | 0.0% |
| Q1 2022 | $14,549,000 | -9.1% | 14,366,000 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $16,006,000 | -9.2% | 15,366,000 | -12.5% | 0.00% | 0.0% |
| Q3 2021 | $17,631,000 | +14.4% | 17,566,000 | +14.7% | 0.00% | 0.0% |
| Q2 2021 | $15,414,000 | – | 15,316,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |